ARTICLE | Company News
DUSA, Noven deal
February 7, 1994 8:00 AM UTC
NOVN (Miami) will develop a transdermal delivery system to treat basal cell carcinoma using 5-Aminolevulinic Acid (ALA), a compound developed by DUSA (Denville, N.J.) for use in photodynamic therapy. ...